Overview of the Upcoming Annual Meeting
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) has exciting news to share with its shareholders regarding the upcoming annual meeting. This gathering is set to take place via a live webcast at 11 a.m. Eastern Time on June 23, 2025. It’s a significant event where stockholders will have the opportunity to voice their opinions and vote on important company matters.
Participation and Voting Process
The Company encourages all stockholders of record as of April 30, 2025, to actively participate in the voting process. It’s crucial for stockholders to review proxy materials that will soon be distributed according to the Securities and Exchange Commission (SEC) regulations. By providing your 16-digit control number found on your Notice of Internet Availability or voting instruction form, you can easily cast your vote during the Annual Meeting.
Importance of Voting
Participating in the voting process is essential as it influences the direction of Tevogen Bio. Stockholders will be asked to vote on the re-election of two incumbent director nominees and the ratification of the Company’s independent registered public accounting firm, reflecting the collective voice of shareholders.
Disclosure of Voting Results
After the annual meeting, Tevogen Bio will disclose the results of the voting through a Form 8-K submission to the SEC. This commitment ensures transparency and keeps shareholders informed of the decisions made regarding the leadership and future of the Company.
Proxy Materials and Important Information
Tevogen Bio will file a proxy statement on Schedule 14A with the SEC in relation to the annual meeting. Shareholders are strongly urged to read this document and any associated materials thoroughly as they will provide vital information about the Company and the meeting proceedings.
Where to Access Proxy Materials
Stockholders can access these important documents for free from the SEC’s website or through the Investors Relations page of Tevogen Bio's website. This ensures that all shareholders can stay informed and make educated decisions regarding their voting options.
Company Leadership and Proxy Solicitation
It’s worth noting that Tevogen Bio and its directors and executive officers may be deemed participants in the solicitation of proxies. Detailed information about these individuals will be included in the proxy statement. Further insights can also be found in the Company's Annual Report and various SEC filings, providing shareholders with a comprehensive view of the leadership structure.
Contact Information for Shareholders
For any inquiries, the shareholder community can reach out to Tevogen Bio Communications. The Company values open communication and encourages stockholders to voice their questions or concerns.
Contact Details
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
Frequently Asked Questions
What is the date and time of the Tevogen Bio Annual Meeting?
The annual meeting will take place on June 23, 2025, at 11 a.m. Eastern Time.
How can I vote as a stockholder?
Stockholders can vote by providing their 16-digit control number found on their Notice of Internet Availability or voting instruction form during the live webcast of the meeting.
What will be discussed during the Annual Meeting?
The meeting will cover the re-election of two incumbent directors and the ratification of the independent accounting firm for Tevogen Bio.
How can I find proxy materials related to the meeting?
Proxy materials will be filed with the SEC and can be accessed through the SEC’s website or the Investor Relations page on Tevogen Bio's website.
Who can I contact for additional information about the meeting?
For inquiries, you can contact Tevogen Bio Communications at 1 877 TEVOGEN, Ext 701, or via email at Communications@Tevogen.com.
